Portable Cell-Free Protein Production With ML Quality Analytics
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing centralized biomanufacturing facilities for protein therapeutics are inflexible, time-consuming, and unreliable, especially in emergency situations, leading to shortages and inconsistent product quality, and there is a need for a portable, on-demand system with real-time quality assurance.
Innovation Solution
A portable, compact bioprocessing system integrating machine learning and on-board analytics for protein production, including a protein expression and purification module, with sensors for data collection and analysis, using cell-free synthesis and chromatography columns, to ensure purity and consistency.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If centralized biomanufacturing facilities are used for protein therapeutics production, then manufacturing precision and reliability are improved, but production time and flexibility deteriorate
Solution Approach 1:
The patent segments the centralized manufacturing process into distributed portable bioreactor units that can operate independently at point-of-care locations. Each portable unit contains integrated expression, purification, and formulation capabilities, allowing local production without relying on centralized facilities.
Solution Approach 2:
The patent transitions from traditional large-scale 2D cell culture to 3D microtissue models that can be maintained in portable bioreactors. This dimensional change enables complex tissue architecture to be preserved while allowing distributed production, reducing both time and quality variability.
2Manufacturing precision
If centralized biomanufacturing facilities are used for protein therapeutics production, then manufacturing precision is improved, but adaptability deteriorates
Solution Approach 1:
The patent implements dynamic control systems in portable bioreactors that can adjust process parameters in real-time based on sensor feedback. This includes automated monitoring of pH, dissolved oxygen, and nutrient levels, allowing each distributed unit to maintain GMP-quality production while adapting to local conditions and demand variations.
Solution Approach 2:
The patent enables rapid parameter changes in portable bioreactors through programmable control systems that can switch between different production protocols. This allows the same hardware platform to produce different protein therapeutics by changing process parameters rather than requiring dedicated facilities for each product.
3Adaptability or versatility
If conventional cell culture manufacture is used for on-demand protein production, then adaptability is improved, but manufacturing precision deteriorates
Solution Approach 1:
The patent incorporates real-time sensor feedback systems in portable bioreactors that continuously monitor critical process parameters and provide automated control adjustments. This feedback mechanism ensures consistent potency and quality even when producing on-demand at distributed locations, eliminating the variability associated with conventional manual compounding approaches.
Solution Approach 2:
The patent implements self-monitoring and self-correcting capabilities in portable bioreactors through integrated sensors and automated control systems. The system automatically detects and corrects process deviations, maintains sterile conditions, and ensures quality consistency without requiring external laboratory testing or manual intervention at each production point.
4Adaptability or versatility
If portable bioprocessing system is used for on-demand protein production, then adaptability and speed are improved, but device complexity increases
Solution Approach 1:
The patent merges expression, purification, formulation, and quality control functions into a single integrated portable bioreactor platform. This consolidation reduces the number of separate equipment pieces needed at point-of-care locations while maintaining GMP-quality production capabilities through shared control systems and standardized protocols.
Solution Approach 2:
The patent designs portable bioreactors with universal, multi-functional capabilities that can produce different protein therapeutics using the same hardware platform. The system accepts various cell lines and expression vectors while maintaining consistent quality through standardized process control, reducing the need for product-specific equipment variations.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The system enables rapid, on-demand production and delivery of high-purity proteins with consistent potency, reducing reliance on laboratory testing and enabling immediate administration at the point-of-care.
Implementation Method 1
The cell-free system includes all the necessary components for transcription and translation
Implementation Method 2
The cell-free system includes all the necessary components for transcription and translation
Implementation Method 3
The purification module comprises a metal ion affinity chromatography column for initial purification and an ion-exchange column for a polishing step
Implementation Method 4
The on-board analytics are integrated to a machine learning system to analyze properties of the bioprocessing system during the production and synthesis of the protein to provide data on the purity, potency and quality
Data Source
AI summary
The present invention relates to cell free protein manufacturing, and more particularly, for integrating machine learning into a portable cell-free bioprocessing system for producing proteins with increased and consistent purity, potency and quality wherein such proteins are prepared on-demand and for point-of-care delivery.